Novartis India Q1 net up 19.15 pc at Rs 37.57 cr
Drug firm Novartis India on Monday said its net profit for the quarter ended June 30, 2011 rose by 19.15 per cent to Rs 37.57 crore.
By PTI | Updated:
NEW DELHI: Drug firm Novartis India on Monday said its net profit for the quarter ended June 30, 2011 rose by 19.15 per cent to Rs 37.57 crore.
The company had posted a net profit of Rs 31.53 crore for the quarter ended June 30, 2010, Novartis India said in a filing to the Bombay Stock Exchange (BSE).
Net sales of the company rose to Rs 188.05 crore for the quarter ended June 30, 2011, as against Rs 168.28 crore for the corresponding quarter last fiscal.
Novartis India is the Indian arm of Novartis International AG, a multinational pharmaceutical company based in Basel, Switzerland.
Shares of Novartis India today closed at Rs 901.05 on the BSE, up 1.06 per cent from its previous close.
The company had posted a net profit of Rs 31.53 crore for the quarter ended June 30, 2010, Novartis India said in a filing to the Bombay Stock Exchange (BSE).
Net sales of the company rose to Rs 188.05 crore for the quarter ended June 30, 2011, as against Rs 168.28 crore for the corresponding quarter last fiscal.
Novartis India is the Indian arm of Novartis International AG, a multinational pharmaceutical company based in Basel, Switzerland.
Shares of Novartis India today closed at Rs 901.05 on the BSE, up 1.06 per cent from its previous close.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
